GlaxoSmithKline Consumer Nigeria PLC 1 Industrial Avenue, Ilupeju

RC 8726

PMB 21218 Ikeja, Lagos

Tel: +234 (01) 2711000, (01) 3242900www.gsk.com/ng

Corporate Actions Announcement

GlaxoSmithKline Consumer Nigeria Plc hereby announce as follows:

Period Ended

31st December 2021

Proposed Dividend

A Dividend of N0.45 kobo per 50 kobo ordinary share from the profit for the year ended 31st December 2021 subject to appropriate withholding tax and approval at the Annual General Meeting will be paid to Shareholders whose names appear in the Register of Members as the close of business on the 22nd April, 2022

Closure of Register

The Register of Shareholders will be closed from Monday, 25th April 2022 to Thursday, 5th May 2022 (both dates inclusive).

Qualification Date

22nd April 2022

Payment Date

On 27th May 2022, dividends will be paid electronically to Shareholders whose names appear in the Register of Members as at 22nd April 2022, and who have completed the e-dividend registration and mandated the Registrar to pay their dividends directly into their Bank accounts.

E-Dividend Registration

Shareholders who are yet to complete the e-dividend registration are advised to download the Registrar's E-Dividend Mandate Activation Form which is available on their website:www.gtlregistrars.com,complete and submit to the Registrar or their respective Banks.

Unclaimed Dividend Warrants and Share Certificates

Shareholders with dividend warrants and share certificates that have remained unclaimed, or are yet to be presented for payment or returned for validation are advised to complete the e-dividend registration or contact the Registrar

Date of Annual General Meeting

The Company's Annual General Meeting will be held at GSK House, 1,

Industrial Avenue, Ilupeju, Lagos on Thursday 26th May, 2022

Registrar

The details of our Registrars are:

Greenwich Registrars & Data Solutions Limited, 274, Murtala Muhammed Way, Yaba.

Phone Number: 01-2793160-2

Email address:info@gtlregistrars.com and website:www.gtlregistrars.com

Investor Relations

Tel. 01-2711000 and Email:ng.investors@gsk.com

Dated this 23rd day of March 2022

Frederick Ichekwai

Company Secretary

Agbara Factory: Km 32, Igbesa Road, Agbara, Ogun State. Tel: +234 (01) 2918000.Email:Customer_ch_nigeria@gsk.com

Directors: Mr. Edmund Onuzo, Chairman; Mr. Kunle Oyelana, Managing Director; Mr. Samuel Kuye; Mr. Mark Pfister (South African), Executive Director, Consumer Healthcare; Mr. Bosco Kirugi (Kenyan), Finance Director; Mrs. Oludewa Edodo-Thorpe; Mr. Oussama Abbas (French); Ms. Amina Salihu

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Glaxo Smithkline Consumer Nigeria plc published this content on 06 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 April 2022 13:21:01 UTC.